J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22

J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021

Transforming Healthcare Through AI

Honeywell launches real-time health monitoring system

Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent

Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline

Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme

Hospitals to accelerate digital investments: Frost & Sullivan

The survey revealed that improving customer experience (CX) and operational efficiencies are top priorities, which healthcare organizations aim to attain by deploying digital health solutions

Astra’s antibody injection trial indicates it can prevent and treat Covid-19

AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial

Sai Life Sciences presents its midterm report

The company has enabled a transformation across three core areas with an investment target of US $ 150 million

IPM growth led by Covid driven products to taper off in Q2FY22: Nirmal Bang

In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report

Wyss Center receives CE mark for Epios Cloud software

The cloud-based platform enables long-term brain monitoring towards personalized treatment

Morpen Labs carves out diagnostics business to unlock value

The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India